The authors also demonstrated that the anti-ADAM15 antibodies inhibited GC cell growth, while the protein was also implicated in the malignant growth of GC cells, similarly to ADAM12, via the interaction with proteolytic ‘shedding’ of signalling molecules or adhesion molecules [46]. Here, ADAM15 is linked to gastric cancer.